Tumor suppressor genes in the TGF-β signaling pathway? Loss of response to TGF-βs may be an important step in the development and progression of cancer. Recent studies show that receptors and proteins involved in TGF-β signaling may act as tumor suppressors

Nature Medicine

Volumn 2, Issue 4, 1996, Pages 390-391

  Serra, Rosa ^a   Moses, Harold L ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CANCER INHIBITION; CHROMOSOME 18Q; HUMAN; NONHUMAN; NOTE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029944116     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0496-390     Document Type: Article

References (15)

1. Tucker, R.F., Shipley, G.D., Moses, H.L. & Holley, R.W. Growth inhibitor from BSC-1 cells closely related to the platelet type beta transforming growth factor. Science 226, 705-707 (1984).
2. Pierce, D.F., Jr., et al. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA 92, 4254-4258 (1995).
3. Blessing, M., Nanney, L.B., King, L.E. & Hogan, B.L.M. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-β related transgene. Teratogen. Carcinogen. Mutagen. 15, 11-21 (1995).
4. Massagué, J., Attisano, L. & Wrana, J.L. The TGF-β family and its composite receptors. Trends Cell Biol. 4, 172-178(1994).
5. Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
6. Chen, R.H., Miettinen, P.J., Maruoka, E.M., Choy, L. & Derynck, R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377, 548-552 (1995).
7. Kawabata, M., Imamura, T., Miyazono, K., Engel, M.E. & Moses, H.L. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J. Biol. Chem. 270, 29628-29631 (1995).
8. Wang, T., Donahoe, P.K. & Zervos, A.S. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265, 674-676 (1994).
9. Alexandrow, M.G. & Moses, H.L. Transforming growth factor β and cell cycle regulation. Cancer Res. 55, 1452-1457 (1995).
10. INK is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
11. Hahn, S.A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353 (1996).
12. Sekelsky, J.J., Newfeld, S.J., Raftery, L.A., Chartoff, E.H. & Gelbart, W.M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139, 1347-1358 (1995).
13. Ruberte, E., Marty, T., Nellen, D., Affolter, M. & Basler, K. An absolute requirement for both the type II and type I receptors, punt and thick veins, for Dpp signaling in vivo. Cell 80, 889-897 (1995).
14. Savage, C. et al. Caenorhabditis elegans genes sma2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl. Acad. Sci. USA 93, 790-794 (1996).
15. Goyette, M.C. et al. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol 12, 1387-1395 (1992).